Neuland Laboratories Limited (NEULANDLAB)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
1715.1
8.45(0.5%)

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

1758.95

TODAY'S LOW

1706.1

52 WEEK HIGH

2002

52 WEEK LOW

967

Major Holders

% of Shares Held by
All Insider

39.52%

% of Shares Held by
Institutions

21.35%

% of Float Held by
Institutions

35.31%

Number of Institutions
Holding Shares

12

Company Overview

MARKET CAP

2240.36 Cr.

ETERPRISE VALUE

2374.73 Cr.

NO. OF SHARES

1.28 Cr.

BOOK VALUE

687.808

DIV. YIELD

5%

DEBT

208.54 Cr.

GROSS PROFIT

398.17 Cr.

CASH

23.06 Cr.

REVENUE

1007.81 Cr.

REVENUE/SHARE

785.405

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments1.66 Cr.18.81 Cr.-5.87 Cr.-15.93 Cr.
Change To Liabilities-39.71 Cr.36.64 Cr.-4.72 Cr.-4.79 Cr.
Total cashflows from Investing Activities-93.70 Cr.-84.42 Cr.-48.67 Cr.-77.22 Cr.
Net Borrowings55.12 Cr.-92.19 Cr.23.83 Cr.-87.57 Cr.
Total Cash from Financing Activities37.72 Cr.-113.66 Cr.-5.48 Cr.11.97 Cr.
Other Liabilities6.83 Cr.70.70 Cr.11.94 Cr.6.29 Cr.
Total Assets000124.50 Cr.
Net Income63.82 Cr.80.63 Cr.16.21 Cr.16.44 Cr.
Change in Cash2.65 Cr.-8.76 Cr.3.26 Cr.4.64 Cr.
Effect of Exchange Rate6.18 Lakhs-4.55 Lakhs8.46 Lakhs-52 k
Total Cash from Operating Activities58.58 Cr.189.36 Cr.57.34 Cr.69.90 Cr.
Depreciation49.04 Cr.38.39 Cr.30.29 Cr.24.86 Cr.
Other Cashflows from Investing Activities1.08 Cr.2.15 Cr.5.20 Cr.1.44 Cr.
Dividends Paid-3.84 Cr.-2.56 Cr.-4.94 Cr.-4.94 Cr.
Change to Inventory-17.60 Cr.-28.06 Cr.-26.89 Cr.-17.56 Cr.
Change to Account Receivables-17.10 Cr.-30.07 Cr.-29.49 Cr.31.53 Cr.
Other Cashflows from Financing Activities-13.55 Cr.-18.89 Cr.-24.36 Cr.-24.95 Cr.
Change to Net Income13.30 Cr.19.83 Cr.59.02 Cr.12.13 Cr.
Capital Expenditures-95.87 Cr.-105.39 Cr.-48.79 Cr.-63.11 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax82.16 Cr.105.33 Cr.52.92 Cr.20.33 Cr.
Minority InterestNoneNoneNoneNone
Net Income93.58 Cr.109.63 Cr.73.59 Cr.38.44 Cr.
Selling General Administrative182.47 Cr.150.45 Cr.124.23 Cr.113.01 Cr.
Gross Profit397.57 Cr.378.27 Cr.286.23 Cr.224.29 Cr.
Ebit93.58 Cr.109.63 Cr.73.59 Cr.38.44 Cr.
Operating Income93.58 Cr.109.63 Cr.73.59 Cr.38.44 Cr.
Other Operating Expenses72.48 Cr.78.50 Cr.57.12 Cr.46.97 Cr.
Interest Expense-13.49 Cr.-11.82 Cr.-16.15 Cr.-9.91 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense18.34 Cr.24.70 Cr.36.71 Cr.3.89 Cr.
Total Revenue951.07 Cr.936.96 Cr.764.02 Cr.667.45 Cr.
Total Operating Expenses857.49 Cr.827.33 Cr.690.42 Cr.629 Cr.
Cost of Revenue553.50 Cr.558.69 Cr.477.79 Cr.443.15 Cr.
Total Other Income Expense Net-11.41 Cr.-4.29 Cr.-20.67 Cr.-18.11 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.63.82 Cr.80.63 Cr.16.21 Cr.16.44 Cr.
Net Income Applicable to Common Shares63.82 Cr.80.63 Cr.16.21 Cr.16.44 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets2.12 Cr.3.49 Cr.1.95 Cr.1.80 Cr.
Capital Surplus0497.77 Cr.497.77 Cr.497.77 Cr.
Total Liabilities542.98 Cr.538.32 Cr.521.02 Cr.431.04 Cr.
Stock Holder Equity840.50 Cr.786.45 Cr.709.95 Cr.699.30 Cr.
Minority Interest0000
Other Liabilities54.69 Cr.83.70 Cr.31.04 Cr.21.79 Cr.
Total Assets1383.48 Cr.1324.78 Cr.1230.97 Cr.1130.35 Cr.
Common Stock12.90 Cr.12.82 Cr.12.82 Cr.12.82 Cr.
Retained Earnings0276.05 Cr.197.99 Cr.186.90 Cr.
Other Liabilities68.64 Cr.72.10 Cr.83.43 Cr.43.34 Cr.
Good Will279.46 Cr.279.46 Cr.279.46 Cr.279.46 Cr.
Treasury Stock827.60 Cr.-20.08 Lakhs1.36 Cr.1.79 Cr.
Other Assets32.05 Cr.60.57 Cr.65.62 Cr.60.31 Cr.
Cash20.35 Cr.2.43 Cr.11.20 Cr.7.93 Cr.
Current Liabilities363.15 Cr.368.51 Cr.357.63 Cr.326.98 Cr.
Long Term Asset Charges0000
Short Long Term Debt126.69 Cr.25.05 Cr.14.04 Cr.21.68 Cr.
Other Stockholder Equity827.60 Cr.-20.08 Lakhs1.36 Cr.1.79 Cr.
Property Plant Equipment486.57 Cr.431.22 Cr.365.09 Cr.334.89 Cr.
Total Cur. Assets582.77 Cr.549.58 Cr.515.18 Cr.453.47 Cr.
Long Term Investments49.74 Lakhs44 Lakhs3.65 Cr.39.92 Lakhs
Net Tangible Assets558.91 Cr.503.49 Cr.428.53 Cr.418.03 Cr.
Short Term Investments3.37 Cr.6.45 Cr.7.50 Cr.7.50 Cr.
Net Receivables234.32 Cr.222.32 Cr.200.46 Cr.177.93 Cr.
Long Term Debt104.24 Cr.88.13 Cr.77.37 Cr.60.71 Cr.
Inventory265.21 Cr.247.60 Cr.219.54 Cr.192.65 Cr.
Accounts Payable112.26 Cr.152.13 Cr.115.56 Cr.119.68 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account